We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $84.4B
1-Year Est. Return 52.68%
This Fund
S&P 500
This Quarter Est. Return
+21.44%
1 Year Est. Return
+52.68%
3 Year Est. Return
+262.56%
5 Year Est. Return
+468.62%
10 Year Est. Return
AUM
$80.6B
AUM Growth
+$3.31B
Cap. Flow
-$2.76B
Cap. Flow %
-3.43%
Top 10 Hldgs %
86.17%
Holding
990
New
330
Increased
137
Reduced
160
Closed
324

Sector Composition

Rank Sector Weight
1 Technology 1.24%
2 Consumer Discretionary 0.34%
3 Communication Services 0.13%
4 Industrials 0.01%
5 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNO icon
576
CALL
United States Brent Oil Fund
BNO
$782M
$16.1K ﹤0.01%
500
VRDN icon
577
CALL
Viridian Therapeutics
VRDN
$2.2B
$15.6K ﹤0.01%
+1,200
New +$16.6K
VFH icon
578
Vanguard Financials ETF
VFH
$13.4B
$15.5K ﹤0.01%
155
-108
-41% -$10.8K
GYRE icon
579
PUT
Gyre Therapeutics
GYRE
$629M
$15.4K ﹤0.01%
+20,000
New +$274K
SMR icon
580
PUT
NuScale Power
SMR
$2.63B
$15.2K ﹤0.01%
1,300
-28,100
-96% -$200K
SLS icon
581
CALL
SELLAS Life Sciences
SLS
$1.99B
$15.1K ﹤0.01%
+12,700
New +$17.3K
AAPU icon
582
PUT
Direxion Daily AAPL Bull 2X ETF
AAPU
$194M
$13K ﹤0.01%
+400
New +$10.5K
TSLQ icon
583
Tradr TSLA Bear Daily ETF
TSLQ
$156M
$12.9K ﹤0.01%
+22
New +$14.7K
NLR icon
584
VanEck Uranium + Nuclear Energy ETF
NLR
$3.67B
$12.6K ﹤0.01%
+157
New +$12.8K
DAPP icon
585
PUT
VanEck Digital Transformation ETF
DAPP
$217M
$12K ﹤0.01%
1,000
-1,900
-66% -$19.8K
ADVM
586
CALL
DELISTED
Adverum Biotechnologies
ADVM
$11.7K ﹤0.01%
+16,900
New +$157K
INO icon
587
CALL
Inovio Pharmaceuticals
INO
$85.6M
$11.6K ﹤0.01%
+17,300
New +$182K
AMDL icon
588
CALL
GraniteShares 2x Long AMD Daily ETF
AMDL
$762M
$11.5K ﹤0.01%
+700
New +$11.8K
NVS icon
589
PUT
Novartis
NVS
$302B
$11.4K ﹤0.01%
+100
New +$10K
VIOG icon
590
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.04B
$11K ﹤0.01%
+100
New +$11K
SQNS
591
Sequans Communications SA
SQNS
$37.4M
$10.7K ﹤0.01%
849
+120
+16% +$1.65K
PPA icon
592
PUT
Invesco Aerospace & Defense ETF
PPA
$8.07B
$10.3K ﹤0.01%
100
SCHG icon
593
PUT
Schwab US Large-Cap Growth ETF
SCHG
$58.2B
$10.1K ﹤0.01%
400
VFH icon
594
PUT
Vanguard Financials ETF
VFH
$13.4B
$9.99K ﹤0.01%
+100
New +$9.98K
NKLA
595
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
$9.97K ﹤0.01%
+39,900
New +$712K
NVD icon
596
PUT
GraniteShares 2x Short NVDA Daily ETF
NVD
$66.1M
$9.72K ﹤0.01%
+176
New +$17.8K
MIDU icon
597
PUT
Direxion Daily Mid Cap Bull 3X ETF
MIDU
$67.3M
$9.58K ﹤0.01%
+200
New +$9.92K
PFIX icon
598
PUT
Simplify Interest Rate Hedge ETF
PFIX
$173M
$9.57K ﹤0.01%
+200
New +$9.81K
SPCE icon
599
CALL
Virgin Galactic
SPCE
$315M
$9.45K ﹤0.01%
+22,500
New +$408K
SMMT icon
600
PUT
Summit Therapeutics
SMMT
$10.2B
$9.36K ﹤0.01%
+1,200
New +$6.48K

Similar funds

Belvedere Trading's Q2 2024 Portfolio in Review

As of Q2 2024, Belvedere Trading held 990 positions worth $80.6B, up 4.3% from $77.3B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Belvedere Trading withdrew a net $2.76B in Q2 2024, closing 324 positions and reducing 160 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, up from 0.8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Belvedere Trading opened a new position in Meta Platforms (Facebook) worth $101M.

  • Belvedere Trading's largest Q2 2024 buy was Meta Platforms (Facebook): 201,182 shares worth $101M.
  • Belvedere Trading added most to NVIDIA in Q2 2024, an estimated $141M increase.
  • Belvedere Trading's biggest Q2 2024 reduction was Apple, cutting an estimated $47.1M.
  • Belvedere Trading fully exited iShares Russell 2000 ETF in Q2 2024, selling an estimated $17.4M.
  • Belvedere Trading's ten largest holdings make up 86% of its $80.6B portfolio in Q2 2024.
  • Belvedere Trading opened 330 new positions and closed 324 in Q2 2024.
  • Belvedere Trading's portfolio value rose 4.3% quarter-over-quarter to $80.6B.

Based on Belvedere Trading's 13F filing for Q2 2024, filed 9 Aug 2024.